Fig. 6
The safety of MoSe2-PVP NPs in vivo. a KM mice body weight treated with saline or MoSe2-PVP NPs (1 mg/mL). b The blood biochemistry parameters. c Biodistribution of MoSe2-PVP NPs in the major organs after intravenous injection for different days. d The vivo toxicity evaluation for the major organs of KM mice by H&E staining. Representative graphics are shown, n = 3 independent experiments